Development of the Mammalian Membrane Two-Hybrid (MaMTH) technology, a novel protein interaction and drug discovery tool

开发哺乳动物膜双杂交 (MaMTH) 技术，一种新型蛋白质相互作用和药物发现工具

• 批准号: 268522
• 负责人: Stagljar Igor
• 金额: $ 11.66万
• 依托单位: University of Toronto
• 依托单位国家: 加拿大
• 项目类别: Operating Grants
• 财政年份: 2012
• 资助国家: 加拿大
• 起止时间: 2012-09-01 至 2013-09-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=268522&lang=en
• 关键词: Cancer Research; Drug Assay Platform; High-Throughput Protein Interaction Assay; Mammalian Membrane Two Hybrid; Protein Protein Interaction; Signalling Pathways

Every cell in the human body contains proteins. They are major part of the skin, muscles, organs, glands and also body fluids. While carrying out the essential functions of our body, proteins don't work in isolation, they form living machines, complexes o

人体内的每个细胞都含有蛋白质。它们是皮肤、肌肉、器官、腺体和体液的主要组成部分。在执行我们身体的基本功能时，蛋白质并不是孤立地起作用的，它们形成了活的机器、复合物或细胞